Levitra

Wenning said Bayer wants to widen its health-care unit and would consider making acquisitions to expand its over-the-counter drug lineup - providing that targets fit Bayer's business plan.

Wenning made the remark at a news conference when asked whether Bayer would bid for Pfizer's over-the-counter division, if it were put up for sale.

Pfizer said last month it might sell or spin off the unit.

Bayer's crop science division had a slight decline in sales of less than 1 percent to 5.89 billion euros ($7.07 billion) while its MaterialScience unit, which produces and sells plastics, reported growth of 24.4 percent to 10.69 billion euros ($12.8 billion) in 2005.

Shares of Bayer were down more than 4 percent to close at 32.41 euros ($39.04) in Frankfurt trading.

- On the Net: http://www.bayer.com © 2006 The Associated Press.

All rights reserved.

This material may not be published, broadcast, rewritten or redistributed.

Learn more about our Privacy Policy.

Purchase this AP story for reprint.

Nation/World NEWS Top Stories U.S.

World Business Technology Sports North Dakota Entertainment Health Politics Offbeat Weather Multimedia Video Gallery The Day in Photos PhotoWeek SportsWeek Today in History Mideast in Depth Yucca Mo...

Read more...